September 15, 2023
Steven C. Campbell, MD, PhD
Program Director and Vice Chair, Department of Urology
Eric A. Klein Chair for Urologic Oncology and Education
Glickman Urological and Kidney Institute, Cleveland Clinic
Dr. Campbell obtained BS, MD and PhD degrees at The University of Chicago and then did a Urology Residency at The Cleveland Clinic (1989-1995), followed by a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center (1995-1996).
Dr. Campbell’s primary interests include renal cell carcinoma, other urologic malignancies, and urology residency training. His background also includes American Foundation for Urological Diseases (AFUD) and Kimmel Research Scholarship Awards. He served on the ABU Exam Committee (1998-2002) and then again as an Editor (2009-2012), and he has served as an examiner for the ABU Part II Exam from 2018-2023.
He has served as Chair of the Exam Committee for the Society of Urologic Oncology (2009-2012) and Secretary/Treasurer and President for the Society of Pelvic Surgeons (2012-2015). Dr. Campbell was Chair for the AUA Guidelines Panel for Management of Localized Kidney Cancer (2014-17, 2021), and was Co-Chair for the previous iteration of this in 2009.
Dr. Campbell is Co-Editor of Renal Cell Carcinoma (BC Decker, 2009) and Editor of Renal Cell Carcinoma: Clinical Management (Humana Press, 2013). He is also Editor of 100 Questions and Answers about Kidney Cancer (Jones and Bartlett, 2008, 2012, 2015, 2018, and 2021). Dr. Campbell has also authored/coauthored “Malignant Renal Tumors” for Campbell/Walsh Urology for the past 6 editions (2000, 2005, 2010, 2015, 2020, and 2023). Dr. Campbell has also served as Chair of an AUA PG Course on RCC for 17 years running, one of the longest such continuous stretches for such a course.
Agenda
Register
To register, contact Tracy T. Phillips, CME Program Coordinator, at tracy.hatt@duke.edu.
Sponsors
- Bayer
- Dendreon
- Pfizer
- Jansse